About Julius clinical
Julius Clinical: A Global Full-Service CRO/SMO Specializing in Brain, ENT, Cardio Metabolic, Infectious Diseases and Immunology
Julius Clinical is a global full-service Contract Research Organization (CRO) and Site Management Organization (SMO) that specializes in clinical research for various therapeutic areas such as Brain, ENT, Cardio Metabolic, Infectious Diseases and Immunology. The company was founded in 2006 by Professor Dr. Hans-Peter Brunner-La Rocca with the aim of providing high-quality clinical research services to pharmaceutical companies and academic institutions worldwide.
With its headquarters located in Zeist, the Netherlands, Julius Clinical has established itself as a leading player in the field of clinical research. The company has a team of highly experienced professionals who are dedicated to providing innovative solutions to complex clinical trial challenges. Julius Clinical's expertise lies in designing and conducting clinical trials that meet regulatory requirements while ensuring patient safety.
The company's services include project management, site selection and management, data management and biostatistics, medical writing and regulatory affairs. Julius Clinical also offers consulting services for protocol development, study design optimization and risk assessment.
One of the key strengths of Julius Clinical is its focus on therapeutic areas such as Brain disorders including Alzheimer’s disease; ENT disorders including hearing loss; Cardio Metabolic diseases including diabetes; Infectious diseases including COVID-19; Immunology disorders including autoimmune diseases like rheumatoid arthritis or lupus erythematosus.
Julius Clinical has extensive experience working with pharmaceutical companies across all phases of drug development from Phase I through Phase IV studies. The company's expertise extends beyond traditional drug development into medical device trials as well.
In addition to its core business activities related to clinical research services for pharmaceutical companies or academic institutions worldwide , Julius Clinical also conducts independent scientific studies aimed at advancing knowledge about various therapeutic areas mentioned above . These studies are often published in peer-reviewed journals which helps establish credibility within the scientific community .
Julius Clinical operates globally with offices located across Europe (the Netherlands), Asia-Pacific region (Singapore), North America (USA) & South America(Brazil). This global presence allows them to provide their clients with access to diverse patient populations while maintaining high standards for quality control throughout all stages of study conduct.
The company prides itself on being at the forefront of innovation when it comes to technology adoption within their operations . They have implemented electronic data capture systems which allow real-time monitoring during trials , reducing errors associated with manual data entry processes . Additionally , they have developed proprietary software tools that help streamline processes related to site selection & recruitment .
In conclusion , Julius Clinical is a leading global full-service CRO/SMO specializing in brain disorders like Alzheimer’s disease ;ENT disorders like hearing loss ;Cardio metabolic diseases like diabetes ;Infectious diseases like COVID-19 ;Immunology disorders like autoimmune diseases such as rheumatoid arthritis or lupus erythematosus . With over 15 years' experience working alongside pharmaceutical companies worldwide , they have established themselves as experts when it comes designing & conducting complex multi-center international trials while ensuring patient safety remains paramount throughout all stages from protocol design through final report submission . Their commitment towards innovation ensures they remain ahead curve when it comes adopting new technologies aimed at improving efficiency within their operations whilst maintaining highest standards quality control possible throughout entire process from start finish!